DexCom (DXCM)
(Delayed Data from NSDQ)
$116.07 USD
-0.57 (-0.49%)
Updated Jun 20, 2024 04:00 PM ET
After-Market: $115.91 -0.16 (-0.14%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum B VGM
Brokerage Reports
0 items in cart
DexCom, Inc. [DXCM]
Reports for Purchase
Showing records 261 - 280 ( 413 total )
Company: DexCom, Inc.
Industry: Medical - Instruments
Takeaways from DXCM and TNDM Management Meetings
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Takeaways from DXCM and TNDM Management Meetings
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
4Q Recap: Reiterate OUTPERFORM on Surprising Profitability and Several Exciting, Upcoming Catalysts; Raising PT to $73
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
CGM Project: Historical survey of 1,428 CGM users (2007 - present)
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
MedTech Stocks To Watch This Week
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
MedTech Stocks To Watch This Week
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
FDA Allows DexCom''s CGM Data to Be Displayed on the iPhone; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Q3 results ahead, guidance raised, maintain SELL on valuation, PT to $37.75
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
Q3 results ahead, guidance raised, maintain SELL on valuation, PT to $37.75
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
3Q Results Solid Across the Board; Increasing PT to $55; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Dexcom Share Approved, Links Patients/Caregivers through iPhone/iPad Touch
Provider: The Benchmark Company
Analyst: WALD J
Company: DexCom, Inc.
Industry: Medical - Instruments
Medical Devices-Takeaways from J&J''s 3Q14 Results
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Strong Second Quarter Sales, Leverage Starts to Kick In - Raising PT to $53 from $50
Provider: The Benchmark Company
Analyst: WALD J
Company: DexCom, Inc.
Industry: Medical - Instruments
Q2 results ahead, guidance raised, maintain SELL on valuation, PT to $28.50
Provider: FELTL & COMPANY